SCHEMBL22789783

SCHEMBL22789783

O=C(O)c1cc(OC2CCCCO2)ccc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACMSD Q8TDX5 3/20 0.48
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
MAOB P27338 1/20 0.40
KDR P35968 2/20 0.40
PDE4A P27815 1/20 0.40
BLVRB P30043 1/20 0.40
HTT P42858 1/20 0.40
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
PTGS2 P35354 2/20 0.39
CA12 O43570 1/20 0.39
ALOX5 P09917 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
HSD11B1 P28845 1/20 0.39
THRB P10828 2/20 0.37
RECQL P46063 2/20 0.37
TDP1 Q9NUW8 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30113210 0.89 MEN1 (0.46) ACMSDMEN1KMT2AMAOBCA1
SCHEMBL18796518 0.89 MEN1 (0.46) ACMSDMEN1KMT2AMAOBCA1
SCHEMBL4119366 0.88 MAOB (0.40) ACMSDMEN1KMT2AMAOBHSD11B1
SCHEMBL3905489 0.86 CA12 (0.46) MEN1KMT2ACA1CA2PTGS2
SCHEMBL18259637 0.83 THRB (0.40) MEN1KMT2ACA1CA2CA12
SCHEMBL21499745 0.83 MEN1 (0.45) MEN1KMT2AMAOBPTGS2HSD11B1
SCHEMBL15654560 0.82 MEN1 (0.47) MEN1KMT2AMAOBHSD11B1KDM4E
SCHEMBL12567807 0.81 TDP1 (0.48) MEN1KMT2ATDP1ALDH1A1CYP3A4
SCHEMBL30065877 0.80 ALDH1A1 (0.50) MAOBALDH1A1CYP3A4HPGD
SCHEMBL2968461 0.80 ALDH1A1 (0.50) MAOBALDH1A1CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200393755-A1 RADIATION-SENSITIVE RESIN COMPOSITION, RESIST PATTERN-FORMING METHOD, COMPOUND, AND METHOD OF CONTROLLING ACID DIFFUSION JSR CORPORATION (JP) 2020-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200393755-A1 RADIATION-SENSITIVE RESIN COMPOSITION, RESIST PATTERN-FORMING METHOD, COMPOUND, AND METHOD OF CONTROLLING ACID DIFFUSION RAD1, SULT1A1, RER1 ACMSD 773/4885MEN1 3479/4885KMT2A 1619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.